143 related articles for article (PubMed ID: 19619644)
1. Up-regulation of TRPV1 in mononuclear cells of end-stage kidney disease patients increases susceptibility to N-arachidonoyl-dopamine (NADA)-induced cell death.
Saunders CI; Fassett RG; Geraghty DP
Biochim Biophys Acta; 2009 Oct; 1792(10):1019-26. PubMed ID: 19619644
[TBL] [Abstract][Full Text] [Related]
2. Vanilloid-like agents inhibit aggregation of human platelets.
Almaghrabi SY; Geraghty DP; Ahuja KD; Adams MJ
Thromb Res; 2014 Aug; 134(2):412-7. PubMed ID: 24953906
[TBL] [Abstract][Full Text] [Related]
3. Increased depressor response to N-arachidonoyl-dopamine during high salt intake: role of the TRPV1 receptor.
Wang Y; Wang DH
J Hypertens; 2007 Dec; 25(12):2426-33. PubMed ID: 17984664
[TBL] [Abstract][Full Text] [Related]
4. Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret.
Sharkey KA; Cristino L; Oland LD; Van Sickle MD; Starowicz K; Pittman QJ; Guglielmotti V; Davison JS; Di Marzo V
Eur J Neurosci; 2007 May; 25(9):2773-82. PubMed ID: 17459108
[TBL] [Abstract][Full Text] [Related]
5. Actions of two naturally occurring saturated N-acyldopamines on transient receptor potential vanilloid 1 (TRPV1) channels.
De Petrocellis L; Chu CJ; Moriello AS; Kellner JC; Walker JM; Di Marzo V
Br J Pharmacol; 2004 Sep; 143(2):251-6. PubMed ID: 15289293
[TBL] [Abstract][Full Text] [Related]
6. N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors.
Marinelli S; Di Marzo V; Florenzano F; Fezza F; Viscomi MT; van der Stelt M; Bernardi G; Molinari M; Maccarrone M; Mercuri NB
Neuropsychopharmacology; 2007 Feb; 32(2):298-308. PubMed ID: 16760924
[TBL] [Abstract][Full Text] [Related]
7. Activation of recombinant human TRPV1 receptors expressed in SH-SY5Y human neuroblastoma cells increases [Ca(2+)](i), initiates neurotransmitter release and promotes delayed cell death.
Lam PM; Hainsworth AH; Smith GD; Owen DE; Davies J; Lambert DG
J Neurochem; 2007 Aug; 102(3):801-11. PubMed ID: 17442052
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of capsaicin-, anandamide-, and N-arachidonoyl-dopamine-evoked cell death in a homogeneous transient receptor potential vanilloid subtype 1 receptor population.
Davies JW; Hainsworth AH; Guerin CJ; Lambert DG
Br J Anaesth; 2010 May; 104(5):596-602. PubMed ID: 20354008
[TBL] [Abstract][Full Text] [Related]
9.
Lawton SK; Xu F; Tran A; Wong E; Prakash A; Schumacher M; Hellman J; Wilhelmsen K
J Immunol; 2017 Aug; 199(4):1465-1475. PubMed ID: 28701511
[No Abstract] [Full Text] [Related]
10. TRPV1 and CB(1) receptor-mediated effects of the endovanilloid/endocannabinoid N-arachidonoyl-dopamine on primary afferent fibre and spinal cord neuronal responses in the rat.
Sagar DR; Smith PA; Millns PJ; Smart D; Kendall DA; Chapman V
Eur J Neurosci; 2004 Jul; 20(1):175-84. PubMed ID: 15245490
[TBL] [Abstract][Full Text] [Related]
11. Expression of transient receptor potential vanilloid 1 (TRPV1) and 2 (TRPV2) in human peripheral blood.
Saunders CI; Kunde DA; Crawford A; Geraghty DP
Mol Immunol; 2007 Feb; 44(6):1429-35. PubMed ID: 16777226
[TBL] [Abstract][Full Text] [Related]
12. The endocannabinoid N-arachidonoyl dopamine (NADA) selectively induces oxidative stress-mediated cell death in hepatic stellate cells but not in hepatocytes.
Wojtalla A; Herweck F; Granzow M; Klein S; Trebicka J; Huss S; Lerner R; Lutz B; Schildberg FA; Knolle PA; Sauerbruch T; Singer MV; Zimmer A; Siegmund SV
Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(8):G873-87. PubMed ID: 22301114
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective Properties of Endocannabinoids N-Arachidonoyl Dopamine and N-Docosahexaenoyl Dopamine Examined in Neuronal Precursors Derived from Human Pluripotent Stem Cells.
Novosadova EV; Arsenyeva EL; Manuilova ES; Khaspekov LG; Bobrov MY; Bezuglov VV; Illarioshkin SN; Grivennikov IA
Biochemistry (Mosc); 2017 Nov; 82(11):1367-1372. PubMed ID: 29223163
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human recombinant T-type calcium channels by the endocannabinoid N-arachidonoyl dopamine.
Ross HR; Gilmore AJ; Connor M
Br J Pharmacol; 2009 Mar; 156(5):740-50. PubMed ID: 19226289
[TBL] [Abstract][Full Text] [Related]
15. The antinociceptive potency of N-arachidonoyl-dopamine (NADA) and its interaction with endomorphin-1 at the spinal level.
Farkas I; Tuboly G; Benedek G; Horvath G
Pharmacol Biochem Behav; 2011 Oct; 99(4):731-7. PubMed ID: 21624393
[TBL] [Abstract][Full Text] [Related]
16. Effects of inhibition of fatty acid amide hydrolase vs. the anandamide membrane transporter on TRPV1-mediated calcium responses in adult DRG neurons; the role of CB receptors.
Millns PJ; Chimenti M; Ali N; Ryland E; de Lago E; Fernandez-Ruiz J; Chapman V; Kendall DA
Eur J Neurosci; 2006 Dec; 24(12):3489-95. PubMed ID: 17229097
[TBL] [Abstract][Full Text] [Related]
17. Endogenous N-acyl-dopamines induce COX-2 expression in brain endothelial cells by stabilizing mRNA through a p38 dependent pathway.
Navarrete CM; Pérez M; de Vinuesa AG; Collado JA; Fiebich BL; Calzado MA; Muñoz E
Biochem Pharmacol; 2010 Jun; 79(12):1805-14. PubMed ID: 20206142
[TBL] [Abstract][Full Text] [Related]
18. The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells.
Wilhelmsen K; Khakpour S; Tran A; Sheehan K; Schumacher M; Xu F; Hellman J
J Biol Chem; 2014 May; 289(19):13079-100. PubMed ID: 24644287
[TBL] [Abstract][Full Text] [Related]
19. N-arachidonyl dopamine sensitizes rat capsaicin-sensitive lung vagal afferents via activation of TRPV1 receptors.
Hsu CC; Bien MY; Huang YT; Ruan T; Kou YR; Lin YS
Respir Physiol Neurobiol; 2009 Jul; 167(3):323-32. PubMed ID: 19539789
[TBL] [Abstract][Full Text] [Related]
20. Anandamide and NADA bi-directionally modulate presynaptic Ca2+ levels and transmitter release in the hippocampus.
Köfalvi A; Pereira MF; Rebola N; Rodrigues RJ; Oliveira CR; Cunha RA
Br J Pharmacol; 2007 Jun; 151(4):551-63. PubMed ID: 17435795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
